You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Jul 31, 2026
Sale
Calculated transaction value
$1.1M
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Jul 30, 2026
Public filing date
Jul 31, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$525.82
Jul 30, 2026
First close after public filing
$516.31
Aug 3, 2026
30-day return after filing
-1.15%
Through Aug 31, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,084 shares @ $525.8
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000110
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$6.27M
Buys / sales
0 / 6
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Jul 30, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Jul 30, 2026 | $336.84K |
| United Therapeutics Corp UTHR | Sale | Jul 30, 2026 | $778.48K |
| United Therapeutics Corp UTHR | Sale | Jul 30, 2026 | $2.54M |
| United Therapeutics Corp UTHR Current | Sale | Jul 30, 2026 | $1.1M |
| United Therapeutics Corp UTHR | Sale | Jul 30, 2026 | $210.77K |
| United Therapeutics Corp UTHR | Sale | Jul 30, 2026 | $21.16K |
| United Therapeutics Corp UTHR | Exercise | Jul 30, 2026 | $0 |